CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 151 filers reported holding CHEMOCENTRYX INC in Q3 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $387,000 | +101.6% | 7,486 | -3.4% | 0.01% | +100.0% |
| Q2 2022 | $192,000 | -3.0% | 7,752 | -1.7% | 0.00% | +33.3% |
| Q1 2022 | $198,000 | -36.9% | 7,885 | -8.4% | 0.00% | -25.0% |
| Q4 2021 | $314,000 | +106.6% | 8,612 | -3.1% | 0.00% | +100.0% |
| Q3 2021 | $152,000 | +47.6% | 8,885 | +15.7% | 0.00% | 0.0% |
| Q2 2021 | $103,000 | -66.9% | 7,682 | +26.6% | 0.00% | -60.0% |
| Q1 2021 | $311,000 | +24.9% | 6,070 | +51.0% | 0.01% | +25.0% |
| Q4 2020 | $249,000 | – | 4,019 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |